These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 34524562)

  • 21. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
    Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E
    Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
    Chong WH; Neu KP
    J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspergillosis: Emerging risk groups in critically ill patients.
    Kluge S; Strauß R; Kochanek M; Weigand MA; Rohde H; Lahmer T
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34677613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Apr; ():. PubMed ID: 34565575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Mitaka H; Kuno T; Takagi H; Patrawalla P
    Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.
    Iacovelli A; Oliva A; Mirabelli FM; Giannone S; Laguardia M; Morviducci M; Nicolardi ML; Repaci E; Sanzari MT; Leanza C; Raponi G; Mastroianni C; Palange P
    BMC Infect Dis; 2024 Apr; 24(1):392. PubMed ID: 38605300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
    Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
    Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
    van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
    J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.
    Gioia F; Walti LN; Orchanian-Cheff A; Husain S
    Lancet Respir Med; 2024 Mar; 12(3):207-216. PubMed ID: 38185135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?
    Rouzé A; Martin-Loeches I; Nseir S
    Curr Opin Crit Care; 2022 Oct; 28(5):470-479. PubMed ID: 35950729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting.
    Hashim Z; Neyaz Z; Marak RSK; Nath A; Nityanand S; Tripathy NK
    J Intensive Care Med; 2022 Aug; 37(8):985-997. PubMed ID: 34678103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Feys S; Almyroudi MP; Braspenning R; Lagrou K; Spriet I; Dimopoulos G; Wauters J
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
    Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
    Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
    Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
    J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive pulmonary aspergillosis in the ICU: tale of a broadening risk profile.
    Koulenti D; Papathanakos G; Blot S
    Curr Opin Crit Care; 2023 Oct; 29(5):463-469. PubMed ID: 37641513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.
    Lupia T; Montrucchio G; Gaviraghi A; Musso G; Puppo M; Bolla C; Shbaklo N; Rizzello B; Della Selva A; Concialdi E; Rumbolo F; Barbui AM; Brazzi L; De Rosa FG; Corcione S
    J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
    Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.